Subsidiary of Zhejiang Yongtai Technology Co. (002326.SZ) received the registration certificate for Lidocaine Prilocaine Cream drug.
Eternal Technology (002326.SZ) announced that its wholly-owned subsidiary, Binhai Meikang Pharmaceutical Co., Ltd., has recently received the "Drug Registration Certificate" for Lidocaine and Prilocaine Cream issued by the National Medical Products Administration.
Zhejiang Yongtai Technology Co., Ltd. (002326.SZ) announced that its wholly-owned subsidiary, Bin Hai Mei Kang Pharmaceutical Co., Ltd., recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the Lidocaine and Prilocaine Cream.
The announcement shows that the Lidocaine and Prilocaine Cream is a compound formulation of Lidocaine and Prilocaine, used for local anesthesia of the skin in the following situations: 1. Needle puncture, such as catheter insertion or taking blood samples; 2. Superficial surgical procedures, such as genital mucosa, before superficial surgery or infiltration anesthesia; leg ulcer cleaning/debridement surgery.
Related Articles

US Stock Market Move | Stock prices continued to fall, with Broadcom Inc. (AVGO.US) dropping over 4%, and its high growth performance being questioned.

US Stock Market Move | Planned $7 billion acquisition of cybersecurity company Armis ServiceNow (NOW.US) leads to a drop of over 10%

US Stock Market Move | Hot Chinese concept stocks collectively fell, Alibaba Group Holding Limited Sponsored ADR (BABA.US) fell more than 3%.
US Stock Market Move | Stock prices continued to fall, with Broadcom Inc. (AVGO.US) dropping over 4%, and its high growth performance being questioned.

US Stock Market Move | Planned $7 billion acquisition of cybersecurity company Armis ServiceNow (NOW.US) leads to a drop of over 10%

US Stock Market Move | Hot Chinese concept stocks collectively fell, Alibaba Group Holding Limited Sponsored ADR (BABA.US) fell more than 3%.

RECOMMEND

Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
12/12/2025

Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
12/12/2025

Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
12/12/2025


